| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Glenda M Halliday, Yun Ju C Song, Antony J Hardin. Striatal β-amyloid in dementia with Lewy bodies but not Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996). vol 118. issue 5. 2011-09-08. PMID:21479514. |
professor jellinger first identified that striatal aβ deposition at postmortem seemed to differentiate cases of dementia with lewy bodies (dlb) from those with parkinson's disease dementia (pdd), a finding subsequently questioned. |
2011-09-08 |
2023-08-12 |
Not clear |
| Glenda M Halliday, Yun Ju C Song, Antony J Hardin. Striatal β-amyloid in dementia with Lewy bodies but not Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996). vol 118. issue 5. 2011-09-08. PMID:21479514. |
cases with dlb had significantly shorter durations and greater dementia severities compared with cases with pdd. |
2011-09-08 |
2023-08-12 |
Not clear |
| Glenda M Halliday, Yun Ju C Song, Antony J Hardin. Striatal β-amyloid in dementia with Lewy bodies but not Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996). vol 118. issue 5. 2011-09-08. PMID:21479514. |
striatal aβ-immunoreactive plaques were only consistently found in cases with dlb and correlated with both the severity (positive correlation) and duration (negative correlation) of dementia. |
2011-09-08 |
2023-08-12 |
Not clear |
| Glenda M Halliday, Yun Ju C Song, Antony J Hardin. Striatal β-amyloid in dementia with Lewy bodies but not Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996). vol 118. issue 5. 2011-09-08. PMID:21479514. |
striatal aβ deposition positively predicted dementia in lewy body cases with high specificity and had the greatest sensitivity to differentiate dlb from pdd with 100% negative predictive value. |
2011-09-08 |
2023-08-12 |
Not clear |
| Kurt A Jellinger, Johannes Attem. Prevalence and pathology of dementia with Lewy bodies in the oldest old: a comparison with other dementing disorders. Dementia and geriatric cognitive disorders. vol 31. issue 4. 2011-09-01. PMID:21502762. |
while the prevalence of alzheimer disease (ad) increases with age, little is known about the frequency of dementia with lewy bodies (dlb) in the oldest old. |
2011-09-01 |
2023-08-12 |
Not clear |
| Fransje E Reesink, Afina W Lemstra, Karin D van Dijk, Henk W Berendse, Wilma D J van de Berg, Martin Klein, Marinus A Blankenstein, Philip Scheltens, Marcel M Verbeek, Wiesje M van der Flie. CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease. Journal of Alzheimer's disease : JAD. vol 22. issue 1. 2011-08-29. PMID:20847452. |
in this study, we assessed whether cerebrospinal fluid (csf) levels of the biomarker α-synuclein have a diagnostic value in differential diagnosis of dementia with lewy bodies (dlb) and alzheimer's disease (ad). |
2011-08-29 |
2023-08-12 |
Not clear |
| Seiju Kobayashi, Masaru Tateno, Tae Woo Park, Kumiko Utsumi, Hitoshi Sohma, Yoichi M Ito, Yasuo Kokai, Toshikazu Sait. Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies. PloS one. vol 6. issue 4. 2011-08-23. PMID:21552550. |
the apolipoprotein e (apoe) ε4 allele has been reported to be a risk factor for alzheimer's disease (ad) and dementia with lewy bodies (dlb). |
2011-08-23 |
2023-08-12 |
human |
| Roberta Frigerio, Hiroshige Fujishiro, Tae-Beom Ahn, Keith A Josephs, Demetrius M Maraganore, Anthony DelleDonne, Joseph E Parisi, Kevin J Klos, Bradley F Boeve, Dennis W Dickson, J Eric Ahlsko. Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies? Neurobiology of aging. vol 32. issue 5. 2011-08-17. PMID:19560232. |
we analyzed ilbd cases (α-synuclein immunohistochemistry) using the braak pd staging scheme and determined if some had a neuropathological pattern suggestive of preclinical dementia with lewy bodies (dlb). |
2011-08-17 |
2023-08-12 |
Not clear |
| Karim Farid, Lisette Volpe-Gillot, Nadine Caillat-Vignero. [Brain SPECT in Lewy body dementia]. Presse medicale (Paris, France : 1983). vol 40. issue 6. 2011-08-16. PMID:21376506. |
dementia of lewy bodies (dlb) is the second cause of degenerative dementia. |
2011-08-16 |
2023-08-12 |
Not clear |
| Karim Farid, Lisette Volpe-Gillot, Nadine Caillat-Vignero. [Brain SPECT in Lewy body dementia]. Presse medicale (Paris, France : 1983). vol 40. issue 6. 2011-08-16. PMID:21376506. |
brain spect is useful in the differential diagnosis between dlb and other dementia. |
2011-08-16 |
2023-08-12 |
Not clear |
| Brit Mollenhauer, Herrmann Esselmann, Claudia Trenkwalder, Walter Schulz-Schaeffer, Hans Kretzschmar, Markus Otto, Jens Wiltfang, Mirko Bib. CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease. Journal of Alzheimer's disease : JAD. vol 24. issue 2. 2011-08-04. PMID:21297274. |
we recently presented differentially expressed amyloid-β (aβ) peptide patterns in cerebrospinal fluid (csf) as biomarker candidates for neurochemical diagnosis of alzheimer's disease (ad) and dementia with lewy bodies (dlb). |
2011-08-04 |
2023-08-12 |
Not clear |
| Argonde C van Harten, Maartje I Kester, Pieter-Jelle Visser, Marinus A Blankenstein, Yolande A L Pijnenburg, Wiesje M van der Flier, Philip Schelten. Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clinical chemistry and laboratory medicine. vol 49. issue 3. 2011-07-27. PMID:21342021. |
to evaluate the value of total tau (tau) and phosphorylated tau (p-tau) in cerebrospinal fluid (csf) in the differential diagnosis of dementia, more specifically: dementia with lewy bodies (dlb), frontotemporal lobar degeneration (ftld), vascular dementia (vad), and creutzfeldt-jacob disease (cjd). |
2011-07-27 |
2023-08-12 |
Not clear |
| Michael Eller, David R William. α-Synuclein in Parkinson disease and other neurodegenerative disorders. Clinical chemistry and laboratory medicine. vol 49. issue 3. 2011-07-27. PMID:21342025. |
it is a 140 amino acid protein that forms the pathological substrate in idiopathic parkinson's disease (ipd), dementia with lewy bodies (dlb), as well as multiple system atrophy (msa), a group of disorders collectively known as the synucleopathies. |
2011-07-27 |
2023-08-12 |
Not clear |
| J E Galvin, J L Price, Z Yan, J C Morris, Y I Shelin. Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease. Neurology. vol 76. issue 21. 2011-07-22. PMID:21525427. |
clinicopathologic phenotypes of dementia with lewy bodies (dlb) and alzheimer disease (ad) often overlap, making discrimination difficult. |
2011-07-22 |
2023-08-12 |
Not clear |
| Pamela J McMillan, James B Leveren. From model system to clinical medicine: pathophysiologic links of common proteinopathies. Alzheimer's research & therapy. vol 2. issue 5. 2011-07-14. PMID:20854651. |
recent clinical evidence suggests that alzheimer disease (ad), parkinson disease (pd), and dementia with lewy bodies (dlb), though distinct neurological disorders, have some common pathological features that may have an impact on the clinical characteristics of these diseases. |
2011-07-14 |
2023-08-12 |
mouse |
| Mirko Bibl, Hermann Esselmann, Piotr Lewczuk, Claudia Trenkwalder, Markus Otto, Johannes Kornhuber, Jens Wiltfang, Brit Mollenhaue. Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia. International journal of Alzheimer's disease. vol 2010. 2011-07-14. PMID:20862375. |
we studied the diagnostic value of csf aβ42/tau versus low aβ1-42% and high aβ1-40(ox)% levels for differential diagnosis of alzheimer's disease (ad) and dementia with lewy bodies (dlb), respectively. |
2011-07-14 |
2023-08-12 |
Not clear |
| Mirko Bibl, Hermann Esselmann, Piotr Lewczuk, Claudia Trenkwalder, Markus Otto, Johannes Kornhuber, Jens Wiltfang, Brit Mollenhaue. Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia. International journal of Alzheimer's disease. vol 2010. 2011-07-14. PMID:20862375. |
csf of 45 patients with ad, 15 with dlb, 21 with parkinson's disease dementia (pdd), and 40 nondemented disease controls (ndc) was analyzed by aβ-sds-page/immunoblot and elisas (aβ42 and tau). |
2011-07-14 |
2023-08-12 |
Not clear |
| Elizabeta B Mukaetova-Ladinska, Rachael Monteith, Elaine K Perr. Cerebrospinal fluid biomarkers for dementia with lewy bodies. International journal of Alzheimer's disease. vol 2010. 2011-07-14. PMID:21048932. |
of these, 5-20% will have dementia with lewy bodies (dlb). |
2011-07-14 |
2023-08-12 |
human |
| Elizabeta B Mukaetova-Ladinska, Rachael Monteith, Elaine K Perr. Cerebrospinal fluid biomarkers for dementia with lewy bodies. International journal of Alzheimer's disease. vol 2010. 2011-07-14. PMID:21048932. |
clinico-pathological studies have shown that it is the low frequency of dlb clinical core features that makes the dlb diagnosis hardly recognisable during life, and easily misdiagnosed for other forms of dementia. |
2011-07-14 |
2023-08-12 |
human |
| Elizabeta B Mukaetova-Ladinska, Rachael Monteith, Elaine K Perr. Cerebrospinal fluid biomarkers for dementia with lewy bodies. International journal of Alzheimer's disease. vol 2010. 2011-07-14. PMID:21048932. |
however, a combination of csf measures appear to emerge, that may well be able to differentiate dlb from other dementias: α-synuclein reduction in early dlb, a correlation between csf α-synuclein and aβ42 measures (characteristic for dlb only), and t-tau and p-tau181 profile (differentiating ad from dlb). |
2011-07-14 |
2023-08-12 |
human |